Further, metformin affected the chemo-resistance of cholangiocarcinoma cells by suppressing the cisplatin-ROS instigated increase in nuclear factor erythroid 2-related factor 2 (NRF2) [180] and inhibited proliferative and invasion potential through STAT3 and NFkB targeting [139]. The gene discussed is NFE2L2; the disease is cholangiocarcinoma.